Published in Zh Nevrol Psikhiatr Im S S Korsakova on January 01, 2003
[Neuroprotective effect of targeted microelectric stimulation in acute cerebrovascular circulation disorders]. Dokl Akad Nauk (1999) 1.08
Structure of the B DNA cationic shell as revealed by an X-ray diffraction study of CsDNA. Sequence-specific cationic stabilization of B form DNA. J Mol Biol (1983) 1.05
[Blood-brain barrier]. Zh Nevrol Psikhiatr Im S S Korsakova (1999) 0.96
Association and linkage of juvenile MS with HLA-DR2(15) in Russians. Neurology (2002) 0.91
Population pharmacokinetic modelling of carbamazepine in epileptic elderly patients: implications for dosage. J Clin Pharm Ther (2006) 0.90
Catalytic heterogeneity of polyclonal DNA-hydrolyzing antibodies from the sera of patients with multiple sclerosis. Immunol Lett (2001) 0.89
Changes in neurotransmitters in multiple sclerosis. Neurosci Behav Physiol (1998) 0.89
The chemokine receptor CCR5 deletion mutation is associated with MS in HLA-DR4-positive Russians. Neurology (2002) 0.88
[Damage of macular ganglion cell complex and peripapillary retinal nerve fiber layer in multiple sclerosis]. Zh Nevrol Psikhiatr Im S S Korsakova (2012) 0.88
The beneficial antispasticity effect of botulinum toxin type A is maintained after repeated treatment cycles. J Neurol Neurosurg Psychiatry (2004) 0.87
[Epidemiological characteristics of multiple sclerosis in Russia]. Zh Nevrol Psikhiatr Im S S Korsakova (2002) 0.85
Studies on the mechanisms of action of proteolytic enzymes using heavy oxygen exchange. Eur J Biochem (1981) 0.85
Polyclonal antibodies from blood and cerebrospinal fluid of patients with multiple sclerosis effectively hydrolyze DNA and RNA. Biochemistry (Mosc) (1998) 0.85
Placebo responses in randomized trials of antiepileptic drugs. Epilepsy Behav (2009) 0.85
Position of caesium ions in crystalline B-form DNA determined by synchrotron radiation diffraction. Preliminary results. J Mol Biol (1979) 0.84
[Multiple sclerosis: molecular and cellular mechanisms]. Mol Biol (Mosk) (1995) 0.83
[Comparative efficacy of different muscle relaxants in the rehabilitation of post-stroke patients with spasticity]. Zh Nevrol Psikhiatr Im S S Korsakova (2008) 0.82
[Histocompatibility antigens in amyotrophic lateral sclerosis patients]. Zh Nevropatol Psikhiatr Im S S Korsakova (1984) 0.82
[Polymorphic variants of genes encoding interleukin-6 and fibrinogen, the risk of ischemic stroke and fibrinogen levels]. Mol Biol (Mosk) (2012) 0.81
[Multiple sclerosis as a polygenic disease: an update]. Genetika (2010) 0.81
[Polymorphism A/G in position +49 of CTLA4 exon 1 in multiple sclerosis in Russians]. Mol Biol (Mosk) (2002) 0.80
[Characteristics of coping strategies in patients with multiple sclerosis(review)]. Zh Nevrol Psikhiatr Im S S Korsakova (2013) 0.80
[Cerebrovascular disorders in patients with coronary bypass surgery]. Zh Nevrol Psikhiatr Im S S Korsakova (2008) 0.80
[Cognitive dysfunction in patients with Parkinson's disease]. Zh Nevrol Psikhiatr Im S S Korsakova (2005) 0.80
Dialectics and implications of natural neurotropic autoantibodies in neurological disease and rehabilitation. Clin Dev Immunol (2004) 0.79
[Neurological disturbances in heroin addicts in acute withdrawal and early post-abstinence periods]. Zh Nevrol Psikhiatr Im S S Korsakova (2003) 0.79
Myelin basic protein gene is associated with MS in DR4- and DR5-positive Italians and Russians. Neurology (2003) 0.78
[Pathomorphological characteristics of unstable bronchial asthma (brittle phenotype)]. Ter Arkh (2008) 0.78
[Effectiveness of semax in acute period of hemispheric ischemic stroke (a clinical and electrophysiological study)]. Zh Nevrol Psikhiatr Im S S Korsakova (1997) 0.78
[The efficacy of the intravenous administration of the trometamol salt of thioctic (alpha-lipoic) acid in diabetic neuropathy]. Zh Nevrol Psikhiatr Im S S Korsakova (1999) 0.78
[Adherence to long-term therapy with disease modifying drugs]. Zh Nevrol Psikhiatr Im S S Korsakova (2009) 0.78
[Lower motor neuron diseases with predominantly upper limbs affection: are they independent forms or atypical variants of amyotrophic lateral sclerosis?]. Zh Nevrol Psikhiatr Im S S Korsakova (2006) 0.78
[A comparative efficiency of amitriptyline, fluoxetine and maprotiline in prevention of migraine in attack-free period]. Zh Nevrol Psikhiatr Im S S Korsakova (2000) 0.78
[The clinico-neurophysiological study of the effect of cerebrolysin on brain function in the acute and early recovery periods of hemispheric ischemic stroke]. Zh Nevrol Psikhiatr Im S S Korsakova (1994) 0.78
[Polymorphism of APOE gene and risk of development of the multiple sclerosis at ethnic Russians]. Mol Biol (Mosk) (2009) 0.78
[Clinicomorphological assessment of budesonide efficiency in patients with bronchial asthma]. Ter Arkh (2003) 0.78
[Neuroprotective treatment with citicoline (ceraxon) in patients with ischemic stroke]. Zh Nevrol Psikhiatr Im S S Korsakova (2012) 0.78
[Fluvoxamine, amitriptyline and transcranial electrostimulation of the brain in the treatment of chronic daily headache]. Zh Nevrol Psikhiatr Im S S Korsakova (2008) 0.78
[Pharmacogenomics of multiple sclerosis: association of immune response genes polymorphism with copaxone treatment efficacy]. Mol Biol (Mosk) (2012) 0.78
[Surgical treatment of temporal lobe epilepsy in patients with marked mental disorders]. Vopr Neirokhir (1972) 0.78
[Connection of multiple sclerosis in the Russian population with alleles of the major histocompatibility complex DRB1 gene]. Mol Biol (Mosk) (1998) 0.78
[Leber's hereditary optic atrophy: neurological and other non-optic appearances]. Zh Nevrol Psikhiatr Im S S Korsakova (2004) 0.77
[The content of free light-chain immunoglobulins in the cerebrospinal fluid and the importance of its determination for the differential diagnosis of multiple sclerosis]. Zh Nevrol Psikhiatr Im S S Korsakova (1994) 0.77
[Semax in prevention of disease progress and development of exacerbations in patients with cerebrovascular insufficiency]. Zh Nevrol Psikhiatr Im S S Korsakova (2005) 0.77
[Role and place of biochemical markers in diagnosis of cerebral ischemic stroke]. Zh Nevrol Psikhiatr Im S S Korsakova (2010) 0.77
[Effective treatment of multiple sclerosis with rebif-22 mcg in children and adolescences: results of a long-term study]. Zh Nevrol Psikhiatr Im S S Korsakova (2006) 0.77
Levels of neurotransmitter amino acids in the cerebrospinal fluid of patients with acute ischemic insult. Neurosci Behav Physiol (2001) 0.77
[The level of autoantibodies to glutamate receptors in the blood serum of patients in the acute period of ischemic stroke]. Zh Nevrol Psikhiatr Im S S Korsakova (1996) 0.77
[The use of katadolon in patients with spondylogenic dorsalgia]. Zh Nevrol Psikhiatr Im S S Korsakova (2006) 0.77
[Treatment of vestibular vertigo and Ménière syndrome in outpatient clinics]. Zh Nevrol Psikhiatr Im S S Korsakova (2012) 0.77
[The role of hemostasis system in the pathogenesis and course of multiple sclerosis]. Zh Nevrol Psikhiatr Im S S Korsakova (2003) 0.77
[Cognitive potential p300 in Parkinson disease]. Zh Nevrol Psikhiatr Im S S Korsakova (2003) 0.77
[Experience in using xeomin in the treatment of arm and hand spasticity in the early rehabilitation phase of stroke]. Zh Nevrol Psikhiatr Im S S Korsakova (2012) 0.77
Gene therapy of amyotrophic lateral sclerosis. Bull Exp Biol Med (2008) 0.77
[Clinical and radiological (PET, MRI) correlations depending on disease progression in patients with multiple sclerosis]. Zh Nevrol Psikhiatr Im S S Korsakova (2006) 0.77
[Possibilities of treatment of multiple sclerosis exacerbations without corticosteroids: a role of metabolic and antioxidant therapy]. Zh Nevrol Psikhiatr Im S S Korsakova (2011) 0.77
[Unified assessment of adverse events of multiple sclerosis disease modifying drugs]. Zh Nevrol Psikhiatr Im S S Korsakova (2014) 0.77
[Epidemiology of multiple sclerosis in Tiumen' region]. Zh Nevrol Psikhiatr Im S S Korsakova (2006) 0.77
[Genome-wide association study as a method for genetic architecture analysis in polygenic diseases (by the example of multiple sclerosis)]. Mol Biol (Mosk) (2015) 0.77
[Comparative efficacy of betaserc and cinnarizine of vertigo in patients with migraine]. Zh Nevrol Psikhiatr Im S S Korsakova (2003) 0.77
[Batroxobin in patients with ischemic stroke in the carotid system (the multicenter study)]. Zh Nevrol Psikhiatr Im S S Korsakova (2006) 0.77
[Computed tomography in the neurological syndromes of spinal osteochondrosis]. Zh Nevropatol Psikhiatr Im S S Korsakova (1992) 0.77
[Borreliae as possible antagonists of tick-borne encephalitis virus: parasitologic and clinical aspects]. Med Parazitol (Mosk) (2001) 0.77
[Tamsulosin in the treatment of detrusor-sphincter dyssynergia of the urinary bladder in patients with multiple sclerosis]. Urologiia (2004) 0.77
[Cognitive dysfunction in elderly patients: diagnosis and treatment]. Zh Nevrol Psikhiatr Im S S Korsakova (2006) 0.76
[The circadian changes of plasma and blood viscosity and hematocrit in patients with ischemic stroke]. Zh Nevrol Psikhiatr Im S S Korsakova (2008) 0.76
[Analysis of linkage and association of alleles of proinflammatory cytokines genes IL-6, IFNg and TNF with multiple sclerosis using transmission disequilibrium test (TDT)]. Mol Biol (Mosk) (2010) 0.76
Impaired production of plasma interleukin-6 in patients with Parkinson's disease. Bull Exp Biol Med (2002) 0.76
[Efficacy of rasagiline in patients with advanced Parkinson's disease with motor fluctuation (azimut study)]. Zh Nevrol Psikhiatr Im S S Korsakova (2010) 0.76
[Disorders of formaldehyde metabolism and its metabolic precursors in patients with multiple sclerosis]. Zh Nevropatol Psikhiatr Im S S Korsakova (1989) 0.76
[Cerebral stroke: problems and solutions]. Vestn Ross Akad Med Nauk (2003) 0.76
Alterations of arginase activity in scrapie-infected mice and in amyotrophic lateral sclerosis. Acta Virol (1990) 0.76
[Diagnostic and pathogenetic implications of the site specificity of antibody proteases in multiple sclerosis]. Vestn Ross Akad Med Nauk (2010) 0.76
[Comparative evaluation of various forms of Parkinson disease in middle-aged and elderly patients (clinical, neuropsychological and computerized-tomographic studies)]. Zh Nevropatol Psikhiatr Im S S Korsakova (1992) 0.76
[On the problem of pathomorphosis of modern tick-borne encephalitis in Ural]. Arkh Patol (2001) 0.76
[Association between DNA antibodies levels in the blood of patients with multiple sclerosis and clinical presentation of the disease]. Zh Nevrol Psikhiatr Im S S Korsakova (2003) 0.76
[Therapeutic effect of encapsulated into the nanocontainers MBP immunodominant peptides on EAE development in DA rats]. Bioorg Khim (2012) 0.76
[Association between the VEGF -2578С/A polymorphism and amyotrophic lateral sclerosis in a Russian population]. Zh Nevrol Psikhiatr Im S S Korsakova (2012) 0.76
Development of antibodies to axonal neurofilaments in the progression of chronic tick-borne encephalitis. Acta Virol (1991) 0.76
[The role of dopamine in the regulation of the interaction between nervous and immune systems in multiple sclerosis]. Zh Nevrol Psikhiatr Im S S Korsakova (2012) 0.75
[The risk factors for the development of multiple sclerosis in the Moscow population. II. The combination of exogenous and hereditary factors]. Zh Nevrol Psikhiatr Im S S Korsakova (1999) 0.75
[Risk factors of multiple sclerosis in Moscow population. I. Exogenous risk factors]. Zh Nevrol Psikhiatr Im S S Korsakova (1999) 0.75